Navigation Links
RNL BIO filed Phase II/III Clinical Trial with KFDA to Treat Cerebral Palsy Using Autologous Fat Derived Stem Cells
Date:2/8/2013

r 1000 male to 2.8 per 1000 female children, averaged at 3.2 per 1000 children, which is expected to increase due to reduction of premature death.

In the clinical study investigators employ a variety of methods to assess efficacy: K-ABC: Kaufman Assessment Battery for Children, Gross Motor Function Measure, (GMFM), box and block test, Modified Asworth Scale, MAS, finger tapping test, Brain SPECT and MRI.

Dr. JC Ra, president of RNL BIO Stem Cell Technology Institute, said, "It is our mission to find cures for incurable diseases, such as the terrible pediatric curse of cerebral palsy, through autologous stem cell technology." 

About RNL BIO

RNL BIO is a premier biotechnology company focused on the research and development of adult derived stem cell technologies. RNL has completed one phase I trial for spinal cord injury and one Phase II clinical trial for Osteoarthritis and is near to the completion of Buerger's Disease trial. RNL has been a supporter of UN Global Compact's free program to work with children who suffer from cerebral palsy, as major sponsor of the Bethesda Life Foundation. RNL is a publicly traded company on the Korean Stock Exchange (Code 003190) and is expanding its operations throughout the world.


'/>"/>
SOURCE RNL BIO
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Faruqi & Faruqi, LLP Notifies Investors of June 4, 2012 Lead Plaintiff Deadline for the Class Action Filed Against Chelsea Therapeutics International
2. Sosei Group Corporation: QVA149 Filed as a Once-Daily Maintenance Treatment for COPD in Europe
3. Sosei Group Corporation: QVA149 Filed by Licensing Partner as a Once-Daily Maintenance Treatment for COPD in Japan
4. Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Abiomed, Inc.
5. Halozyme Announced Roche Filed A Marketing Authorization Application For Subcutaneous MabThera
6. Lotus Pharmaceutical Company Inc. Filed Its Abbreviated New Drug Application (ANDA) Containing a Paragraph IV Certification for a Generic Version of Xenical(R) with the U.S. Food & Drug Administration (FDA)
7. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
8. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
9. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
10. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
11. Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... ORLANDO, Fla. , Nov. 21, 2014 MEDITE ... 2014 reported nine months and the 3 rd quarter ... million. Operating income was $448,000 for the nine months ended ... September 2014. "Even though our 3 rd quarter is ... period which extends from July into September for many countries ...
(Date:11/21/2014)... COLLEGE PARK, Md. , Nov. 21, 2014 /PRNewswire-USNewswire/ ... Engineering today will host the ceremonial groundbreaking of the ... Maryland, College Park. The new building will cultivate transformative ... human health.  Taking place at 10:00 a.m. ... building in the Paint Branch Parking Lot, adjacent to ...
(Date:11/21/2014)...  World Hemp Oil, an importer of oil extracted ... now offering legal, organic oil with high CBD (cannabidiol) ... in medical marijuana states. People suffering from epileptic seizures ... MS, and spinal cord injury, no longer have to ... CBD Oil Is legal in all states. ...
Breaking Medicine Technology:CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales 2CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales 3University of Maryland Breaks Ground for A. James Clark Hall 2University of Maryland Breaks Ground for A. James Clark Hall 3University of Maryland Breaks Ground for A. James Clark Hall 4New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 3
... Oct. 5 Watson Pharmaceuticals, Inc. (NYSE: ... Inc., filed an Abbreviated New Drug Application (ANDA) with ... to market rasagiline mesylate 0.5 and 1.0 mg tablets. ... Neuroscience, Inc.,s Azilect® Tablets, which are indicated for the ...
... bacteria is normally very toxic when ingested, even deadly. However, ... illness and instead kill cancer cells. Salmonella likes ... observed in the 1890s, but only recently exploited with the ... variations. Genetically-modified Salmonella "eats" cancer ...
Cached Medicine Technology:Watson Confirms Azilect® Patent Challenge 2Watson Confirms Azilect® Patent Challenge 3Botanic Oil Innovations Funds Human Clinical Study Using Non-Toxic Salmonella as Cancer Medicine 2
(Date:11/22/2014)... A new AlignLife Chiropractic & Natural Health Center ... area. Dr. Chelsea Sineath, owner and chiropractor at ... own clinic after working in another AlignLife office and ... AlignLife believes that the body can heal itself when ... care and rehabilitation to allow the spine to maintain ...
(Date:11/22/2014)... 23, 2014 A classic black prom dress ... most famous dress suppliers, has unveiled its new items of ... are now offered at a big discount, up to 70% ... , The new black prom dresses, made with the ... meet the needs of all customers, the company provides these ...
(Date:11/22/2014)... New York, NY (PRWEB) November 22, 2014 ... Australia’s Therapeutics Goods Administration (TGA) approved it for ... Glutathione was approved and listed within the Therapeutic ... http://www.comlaw.gov.au/Details/F2014L01277 , Kyowa Hakko’s Setria® Glutathione ... Chem, a biotech specialist that sources and imports ...
(Date:11/22/2014)... (PRWEB) November 22, 2014 Nocturia ... as the complaint that the individual has to ... voiding. The report “Nocturia – Pipeline Review, H2 ... for Nocturia, complete with comparative analysis at various ... action (MoA), route of administration (RoA) and molecule ...
(Date:11/22/2014)... News) -- The wide variety and complexity of foods ... people with food allergies, an expert warns. "Every ... of food allergies that it can be really difficult ... Krishnaswamy, director of allergy and clinical immunology at Wake ... release. "If you know you have food allergies, ...
Breaking Medicine News(10 mins):Health News:AlignLife of Downtown Greenville is Now Open and Accepting New Patients 2Health News:New Black Prom Dresses from BellasDress.com 2Health News:Setria® Glutathione Now Available in Australia 2Health News:Setria® Glutathione Now Available in Australia 3Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 2Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 3Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 4Health News:'Tis the Season of Challenges for Those With Food Allergies 2
... , MONDAY, Nov. 14 (HealthDay News) -- A once-promising drug ... actually seems to raise the odds for patient death, a ... against the non-chronic, "intermittent" form of atrial fibrillation in prior ... ongoing, "permanent" atrial fibrillation -- use of dronedarone was tied ...
... in the Princess Margaret Cancer Program have found a promising ... new way. The proof-of-concept research published today in ... discovered that the antibiotic tigecycline targets and destroys leukemia stem ... you think of all the cells in the body as ...
... MONDAY, Nov. 14 (HealthDay News) -- Aggression in childhood is ... as a health risk, a new study says. Researchers ... Quebec who were in first, fourth and seventh grades in ... 1992 and 2006. The results showed that childhood aggression ...
... Washington Research released today shows that scientists ... disorders like autism and fragile X syndrome. These ... connections, chemicals, and genes interact to affect behavior. ... the Society for Neuroscience,s annual meeting and the ...
... Chris Seaton, formerly a captain in the Royal Army ... Science at The University of Manchester, created the easy-to-use ... burns caused to fellow soldiers. Chris, who ... and Professor Paul McArthur, plastic surgeons at St Helens ...
... to die from infectious diseases like measles or even AIDS, ... (NCDs), as they are now the leading causes of deaths ... In a world of 7 billion people with changing disease ... external lecturer Siri Tellier from the Copenhagen School of Global ...
Cached Medicine News:Health News:Experimental Drug for Irregular Heart Rhythm Raises Death Risk: Study 2Health News:Experimental Drug for Irregular Heart Rhythm Raises Death Risk: Study 3Health News:Canadian researchers find potential new leukemia treatment with old antibiotic drug 2Health News:Childhood Aggression May Predict Health Woes in Adulthood 2Health News:Research provides clues to neurodevelopemental disorders 2Health News:Burns app could save lives at the touch of a button 2Health News:Risk of contracting diabetes to increase in world of 7 billion people 2Health News:Risk of contracting diabetes to increase in world of 7 billion people 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: